NDC 82922-005 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-005
- Package NDCs from labels
- 82922-005-02
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METRONIDAZOLE - Truemed Group LLC | Truemed Group LLC | 2022-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 8b2c294b-ed70-447c-bbc4-2a8b59f1aca4 | 2023-10-25 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole vaginal | METRONIDAZOLE | Padagis Israel Pharmaceuticals Ltd | eb240e7b-cec8-497b-8a49-7ed768e2b431 | 2023-07-25 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | d76810d5-11b4-4b5e-b850-230f59376c34 | 2023-07-18 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Zydus Lifesciences Limited | 728ebe6d-7a20-481d-845a-ceffa450179f | 2023-05-05 | 140QMO216E | |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | bff2f5bd-75a4-4252-a643-c21741ae8a96 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | a0d7d4e8-28c0-4211-8d76-73a173b48d9a | 2023-01-31 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | 80c79325-1ea4-46f8-b9b8-967b7640c51d | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | d7455566-16aa-488a-af2a-93b55a04c02f | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | 387053e5-7eda-4282-b58a-5789430a2e99 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Proficient Rx LP | 205054e1-8172-47dc-931c-a18a60e7e9f0 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | 86da8d86-5ab2-f668-fdfd-b0e93e6a2245 | 2022-11-21 | Adverse reactions | 140QMO216E |
| ed8b2c7a-0799-47f6-e053-2995a90afbb2 | e5c04310-0d37-03cd-e053-2995a90a4854 | 2022-11-15 | e5c04310-0d37-03cd-e053-2995a90a4854 | |||
| Metronidazole | METRONIDAZOLE | PharmPak, Inc. | be23affb-5b30-40ee-b0b5-829666bafaeb | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PharmPak, Inc. | 6a77b5b6-3199-4526-bd68-2e511353d7c6 | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Labs LLC | 86415209-5440-41da-abb8-e1a3d5051f91 | 2022-06-24 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Oceanside Pharmaceuticals | cdf2e251-4bbc-4434-9b00-bef6284491e4 | 2022-06-21 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | AvPAK | 9623181f-5e3b-3695-e053-2a95a90a99f6 | 2022-05-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Noritate | METRONIDAZOLE | Bausch Health US, LLC | 706b09da-6cf9-421d-8e91-f3999474d322 | 2020-06-01 | Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.